AVTX Stock Analysis: Buy, Sell, or Hold?
AVTX - Avalo Therapeutics, Inc. Common Stock
$19.27
-0.56 (-2.82%)
▼
5d:
-3.41%
30d:
+4.5%
90d:
+17.86%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When AVTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AVTX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AVTX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: AVTX is currently trading at $19.27, which is considered extended relative to its 30-day fair value range of $18.28 to $19.54.
Technical Outlook: Technically, AVTX is in a uptrend. Immediate support is located at $18.34, while resistance sits at $21.02.
Market Sentiment: AVTX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $44.15 (+129.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AVTX is in a uptrend. Immediate support is located at $18.34, while resistance sits at $21.02.
Market Sentiment: AVTX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $44.15 (+129.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.28 -
$19.54
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 129.1% below Wall St target ($44.15)
- WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$18.28 -
$19.54
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$18.34
Resistance Level
$21.02
Current Trend
Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.32
Wall Street Target
$44.15
(+129.1%)
Revenue Growth (YoY)
-69.3%
Share & Embed Analysis
Last updated: August 24, 2026 8:52 PM ET
Data refreshes hourly during market hours. Next update: 9:52 PM
Data refreshes hourly during market hours. Next update: 9:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Mittie Doyle
SELL
3970 shares
2026-04-06
Christopher Ryan Sullivan
SELL
7980 shares
2026-04-02
Christopher Ryan Sullivan
SELL
7979 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 46 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 68 BUY |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
13 analysts |
$19 | 51 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 32 SELL |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 39 SELL |
